Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic effects of diltiazem sustained-release capsules in coronary slow flow phenomenon
ChiCTR-TCC-11001864Phase 4Completed
- Sponsor
- Wuhan Fourth Hospital
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of diltiazem in Slow Coronary Flow (SCF) (2 arms), sponsored by Wuhan Fourth Hospital. Primary endpoint: Symptoms. Started Mar 2004; status: completed.
02
Drugs
diltiazem
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on ChiCTR-TCC-11001864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TCC-11001864.